Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing